|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA01020397
|
Argenonic acid
|
6-hydroxy-6-methyl-9-oxooctacosanoic acid
|
FA 29:1;O2
|
C29H56O4
|
468.417861
|
|
LMFA04020092
|
(10R,13S,17R)-d15-11-NeuroF[11S,14S]
|
(R,4Z,7Z)-10-hydroxy-10-((2S,4S,5S)-4-hydroxy-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020112
|
(10S,13S,17S)-d15-11-NeuroF[11S,14S]
|
(S,4Z,7Z)-10-hydroxy-10-((2S,4S,5S)-4-hydroxy-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020124
|
(10R,14S,17R)-d11-13-NeuroF[13R,16R]
|
(R,4Z,7Z,11E)-10-hydroxy-12-((2R,3S,5R)-3-hydroxy-5-((R,Z)-1-hydroxyhex-3-en-1-yl)tetrahydrofuran-2-yl)dodeca-4,7,11-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020136
|
(10S,14R,17S)-d11-13-NeuroF[13R,16R]
|
(S,4Z,7Z,11E)-10-hydroxy-12-((2R,3R,5R)-3-hydroxy-5-((S,Z)-1-hydroxyhex-3-en-1-yl)tetrahydrofuran-2-yl)dodeca-4,7,11-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020235
|
(4S,7S,11R)-d9-5-NeuroF[5S,8R]
|
(S)-4-hydroxy-4-((2S,4S,5R)-4-hydroxy-5-((R,1E,5Z,8Z,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)tetrahydrofuran-2-yl)butanoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020257
|
(4S,8R,11R)-d5-7-NeuroF[7S,10S]
|
(S,E)-4-hydroxy-6-((2S,3R,5S)-3-hydroxy-5-((R,3Z,6Z,9Z)-1-hydroxydodeca-3,6,9-trien-1-yl)tetrahydrofuran-2-yl)hex-5-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020271
|
(4S,8S,11S)-d5-7-NeuroF[7R,10S]
|
(S,E)-4-hydroxy-6-((2R,3S,5S)-3-hydroxy-5-((S,3Z,6Z,9Z)-1-hydroxydodeca-3,6,9-trien-1-yl)tetrahydrofuran-2-yl)hex-5-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020284
|
(14R,17S,20R)-d18-13-NeuroF[13R,16R]
|
(4Z,7Z,10Z)-12-((2R,3R,5R)-5-((1S,4R,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)dodeca-4,7,10-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020295
|
(14S,17R,20S)-d18-13-NeuroF[13R,16S]
|
(4Z,7Z,10Z)-12-((2R,3S,5S)-5-((1R,4S,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)dodeca-4,7,10-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020313
|
(13R,16S,19R)-d14-17-NeuroF[17a,20a]
|
(4Z,7Z,10Z,13R,14E,16S)-16-((2R,4R,5R)-5-ethyl-4-hydroxytetrahydrofuran-2-yl)-13,16-dihydroxyhexadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA01050566
|
9-hydroxy-traumatin
|
9-hydroxy-12-oxo-10E-dodecenoic acid
|
FA 12:2;O2
|
C12H20O4
|
228.136160
|
|
LMFA04020331
|
(13S,16S,19R)-d14-17-NeuroF[17b,20a]
|
(4Z,7Z,10Z,13S,14E,16S)-16-((2S,4R,5R)-5-ethyl-4-hydroxytetrahydrofuran-2-yl)-13,16-dihydroxyhexadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020412
|
(8R,11S,14R)-d12-7-NeuroF[7R,10R]
|
(Z)-6-((2R,3R,5R)-5-((1S,2E,4R,6Z,9Z)-1,4-dihydroxydodeca-2,6,9-trien-1-yl)-3-hydroxytetrahydrofuran-2-yl)hex-4-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020414
|
(8R,11S,14S)-d12-7-NeuroF[7S,10R]
|
(Z)-6-((2S,3R,5R)-5-((1S,2E,4S,6Z,9Z)-1,4-dihydroxydodeca-2,6,9-trien-1-yl)-3-hydroxytetrahydrofuran-2-yl)hex-4-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA03130094
|
(8S,11R,14S)-d9-12-IsoF[12R,15S]
|
(5Z,8S,9Z,11R)-8,11-dihydroxy-11-((2R,4S,5S)-4-hydroxy-5-pentyltetrahydrofuran-2-yl)undeca-5,9-dienoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA03130113
|
(6R,9S,12R)-d10-5-IsoF[5S,8S]
|
4-((2S,3R,5S)-5-((1S,2Z,4R,6Z)-1,4-dihydroxydodeca-2,6-dien-1-yl)-3-hydroxytetrahydrofuran-2-yl)butanoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA04020315
|
(13R,16S,19R)-d14-17-NeuroF[17b,20a]
|
(4Z,7Z,10Z,13R,14E,16S)-16-((2S,4R,5R)-5-ethyl-4-hydroxytetrahydrofuran-2-yl)-13,16-dihydroxyhexadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020379
|
(10R,13S,16R)-d11-14-NeuroF[14S,17R]
|
(4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-((2S,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020425
|
(8S,11S,14R)-d12-7-NeuroF[7S,10S]
|
(Z)-6-((2S,3S,5S)-5-((1S,2E,4R,6Z,9Z)-1,4-dihydroxydodeca-2,6,9-trien-1-yl)-3-hydroxytetrahydrofuran-2-yl)hex-4-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020496
|
(5S,8S,11S)-d9-4-NeuroF[4R,7R]
|
3-((2R,3S,5R)-5-((1S,2E,4S,6Z,9Z,12Z)-1,4-dihydroxypentadeca-2,6,9,12-tetraen-1-yl)-3-hydroxytetrahydrofuran-2-yl)propanoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020512
|
(4R,7S,10S)-d5-8-NeuroF[8S,11S]
|
(4R,7S,E)-4,7-dihydroxy-7-((2S,4S,5S)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020429
|
(8S,11S,14S)-d12-7-NeuroF[7S,10S]
|
(Z)-6-((2S,3S,5S)-5-((1S,2E,4S,6Z,9Z)-1,4-dihydroxydodeca-2,6,9-trien-1-yl)-3-hydroxytetrahydrofuran-2-yl)hex-4-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA03130036
|
(5S,9S,12R)-d6-8-IsoF[8R,11R]
|
(S,E)-5-hydroxy-7-((2R,3S,5R)-3-hydroxy-5-((R,Z)-1-hydroxynon-3-en-1-yl)tetrahydrofuran-2-yl)hept-6-enoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA01050571
|
Gallicynoic acid H
|
9S,12R-dihydroxy-hexadeca-10-ynoic acid
|
FA 16:2;O2
|
C16H28O4
|
284.198761
|
|
LMFA03110205
|
ent-8-E2t-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1R,2S,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA04010242
|
ent-17-epi-17-D4t-NeuroP
|
(4Z,7Z)-9-((1S,2R,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010243
|
17-epi-17-D4c-NeuroP
|
(4Z,7Z)-9-((1R,2S,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010013
|
ent-7-epi-4-F4t-NeuroP
|
(R,E)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA04010029
|
ent-10-epi-7-F4t-NeuroP
|
(R,4Z,8E)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA04010070
|
ent-11-epi-4-Fc-NeuroP
|
3-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA04010331
|
ent-13-E4t-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1R,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010049
|
10,13-diepi-10-F4c-NeuroP
|
(R,4Z,7Z,11E)-12-((1S,2S,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA03130189
|
(8S,11R,15S)-d13-9-IsoF[9R,12R]
|
(S,Z)-8-hydroxy-8-((2R,4R,5R)-4-hydroxy-5-((S,E)-3-hydroxyoct-1-en-1-yl)tetrahydrofuran-2-yl)oct-5-enoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA12000341
|
BBTOH
|
(E)-4-(thiophen-2-yl)but-1-en-3-yn-1-ol
|
|
C8H6OS
|
150.013936
|
|
LMFA02040034
|
(9S,12S,15S)-d10-13-PhytoF[13R,16S]
|
(9S,12S,E)-12-((2R,4S,5S)-5-ethyl-4-hydroxytetrahydrofuran-2-yl)-9,12-dihydroxydodec-10-enoic acid
|
FA 18:2;O4
|
C18H32O6
|
344.219891
|
|
LMFA02040098
|
(10S,13S,16S)-d14-9-PhytoF[9S,12R]
|
8-((2S,3S,5R)-5-((1S,4S,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)octanoic acid
|
FA 18:2;O4
|
C18H32O6
|
344.219891
|
|
LMFA02040118
|
(9S,12R,16R)-d14-10-PhytoF[10R,13S]
|
(S)-9-hydroxy-9-((2R,4R,5S)-4-hydroxy-5-((R,E)-3-hydroxypent-1-en-1-yl)tetrahydrofuran-2-yl)nonanoic acid
|
FA 18:2;O4
|
C18H32O6
|
344.219891
|
|
LMFA02030034
|
ent-9-epi-9-D1c-PhytoP
|
(S,E)-11-((1S,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-9-hydroxyundec-10-enoic acid
|
FA 18:3;O3
|
C18H30O5
|
326.209326
|
|
LMFA01050562
|
9S-HHTrE
|
9S-hydroxy-6Z,10E,12Z-hexadecatrienoic acid
|
FA 16:3;O
|
C16H26O3
|
266.188195
|
|
LMFA04010478
|
ent-10-J4-NeuroP
|
(R,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214411
|
|
LMFA01140081
|
2-[5]-ladderane ethanoic acid
|
2-[5]-ladderane ethanoic acid
|
FA 14:5
|
C14H18O2
|
218.130680
|
|
LMFA04010306
|
10-epi-10-E4t-NeuroP
|
(R,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010157
|
ent-10-epi-7-D4t-NeuroP
|
(R,4Z,8E)-7-hydroxy-9-((1S,2S,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010185
|
13-epi-10-D4c-NeuroP
|
(S,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010435
|
14-epi-14-A4-NeuroP
|
(Z)-6-((1R,2R)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214411
|
|
LMFA04010503
|
14-J4-NeuroP
|
(Z)-6-((1S,5S)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214411
|
|
LMFA12000336
|
Falcarinone
|
1,9Z-heptadecadien-4,6-diyn-3-one
|
|
C17H22O
|
242.167065
|
|
LMFA03110318
|
ent-14-epi-14-F2t-dihomo-IsoP
|
1a,1b-dihomo-8R,10S,14R-trihydroxy-12E,16Z-prostadienoic acid-cyclo[7S,11S]
|
FA 22:3;O3
|
C22H38O5
|
382.271926
|
|
LMFA12000370
|
(E)-3-(hexa-3,5-dien-1-yn-1-yl)-6-(prop-1-yn-1-yl)-1,2-dithiine
|
(E)-3-(hexa-3,5-dien-1-yn-1-yl)-6-(prop-1-yn-1-yl)-1,2-dithiine
|
|
C13H10S2
|
230.022392
|